Wim, All three of your last posts are legitimate arguments. I think we have seen his true color now. The fact they stated that the RS was going to effect everyone the same and just 5 months later now change it that his subordinated Debentures will not be subject to the RS so he does not get diluted. well, that speaks volumes. He does not have time to work on marketing his drugs but he had time to do that.

So if that is the caliber of CEO we have,of course he will just dilute again. Once he gets the 1.7 million shares convertible at 54 cents that not gets him back to owning above 10% of the company. He can afford to dilute again. This is why he is doing this. So he can dilute again while maintaining control.

You are correct in that the BOD is responsible for allowing this continue. It just shows that no one will then take the company serious and we will probably be stuck at these levels.

We already know the games that were played to manipulate the price. The people who play these games are probably just as upset with Odidi as we are. So, do you really think they will allow the price to get above that 56 cents to allow him to covert those shares? My guess is they will not. The only way to stop him is by not allowing the share price to get above the strike price.

If I am correct then we are going to be stuck in this trading range of 17 cents to 40 cents for a very long time.

Wim, That is an interesting way to put things. so they spent too much time trying to save NASDAQ listing and that is why they didn't do anything else last year?

Ironically, had they done something else, like ink a deal for Rexista or Regabatin, they would have saved the NASDAQ listing.

Seriously, for someone with a MBA in business, well I guess I do not need to state the obvious. Its just like taking the time to renegotiate his subordinated debentures. When they originally filed the reverse split they stated the split was to effect everyone. Now, he changes his mind and is making sure he doesn't get diluted on a loan that the money was spent years ago. or maybe that was the intent all along? telling shareholders one thing and do another? I see a pattern here.

well, the 1QE is out and most items as expected with the exception of one thing which I call BS on. the refinancing of the Debentures.

Numbers, nice to see you here. well sorta that means your holding a bag as well. You are right about Renexa. that is something the company has never kept us informed on. They filed that under the new regs so the FDA was to give a response within 10 months. So only way they can get approval is assuming they did not receive any CRL.

Honestly they had the chance to get on the leading edge f so many drugs and they blow it every time. Regabatin for one. They have been siting on that since 2015 knowing they needed a partner. Had they partnered back then they would have been set to roll it out before the end of the Lyrica patent. Now they will have to compete with generics. Seroquel! they fail to capitalize on that and companies who got approval AFTER IPCI got more market share than we did. to this day they have not made a effort to sell it nor have they held MNK accountable.

It is become apparent, Odidi thinks he is successful merely because he obtains a patent or an approval rather than the actual success of the company. which is why he feels he is justified in his millions of salary and bonuses a year while not doing anything to provide shareholder value but only diluting it.

approved drugs sitting on a shelf collecting dust. approved drugs which are partnered not being marketed properly and doing nothing. proposed NDA's sitting on a shelf since 2015 not being partnered so no progress on the pipeline. Yet, he feels that is success worthy of top notch pay and bonuses. Worse of all we have a BOD that does nothing about it.

Doog, you are correct. his comment that its time to rebuild is pathetic. If he could not keep it from falling apart when it was up, what makes him think he can rebuild? there should have been no need to rebuild. All he needed to do is sign a deal. If he wasn't willing to make a deal to save the company, why would we think he is willing to make a deal to build one?

Wim, not only does any of the people buying the offerings want him him out neither does the board. They have turned a blind eye to his performance. It makes sense that the people behind the offerings do not want him out. He hands them this game on a platter. His last offering he sold what, a total of 20 million shares for 14 million dollars when we only had 5 million outstanding after the reverse split. Those holders can now use those same shares to short him back down on his next offering. So they make their money shorting against him. And he has proved them right time and time again that he can not deliver so betting against him is the smart bet.

I agree it appears they are setting up for another run now. They are slowly covering the short position now. That is why we are seeing this slowly increase in price on no news. so right before the next offering they can short it back down forcing him to issue more shares at even lower prices.

Wim, I agree that with the performance of the company the BOD has some explaining to do. as you pointed out we went from 100 mil market cap to where we currently sit and no adjustments from their end either.

I did write them after the the adcomm and expressed my opinions and hey never did get back to me. Now things even got worse from that point.

I read on a another site (and did you note the one site is now removed?) but I read on another where the CFO claims this time is to rebuild the company.

How the H is someone going to rebuild when they were not able to maintain and expand what they had? It is sad the state of affairs we were drug into but as you said, its a great little pump and dump cash machine for some and as long as Odidi gets his millions a year in salary and bonuses he thinks he's running a successful business.

Wim, you are quite right. Unless he finally makes a deal he will be doing nothing more than more diluting by or before May. It is was kept me stuck here all last year. He puts out a PR stating they are evaluating offers for Regabatin and even stated they intended to start trials by year end and they only quantified the statement by saying assuming they have the money. So if they had offers one would have expected them to take one of them before allowing the company to fail NASDAQ compliance as well as do the toxic dilutions they did.

So did they even have offers? Any offer, even if it was for only 5 million dollars plus the partner pays for trials, would have been better than falling off NASDAQ and letting the drug and pipeline sit on a shelf.

GV, not only did it go down after hours but the slide continues today. on very heavy trading. almost 4.5 million shares as of now. My guess is, someone in the know, got wind of a possible drop in dividend and the price is being adjusted down to reflect a newer distribution rate. They have been returning on Capital for sometime and I felt they may lower the dividend.

Ex dividend date should announced soon so we shall see if they reduced the payout. If they don't then all I can say is some institution which held a lot of shares just decided to sell out and it crashed the share price.

Trend, I saw that and what did that do for us? Got us back to $0.23 cents. I guess no news will pop us, but bad news will always destroy us. It is what I have been complaining about for a long time.

doog, well said. I said back then IPCI should have sued the FDA for that decision. by trying to placate them or not antagonize them, what did they gain? ZERO !

Wim, You, are correct he is the one common denominator. Had he not needed to raise the cash we would have been ok after the RS. The sharks were just waiting loving the fact he did the RS. it gave them room to move the stock downward. It was easier to run the stock from $3.50 to the current $0.20 cents than it would have been to lower the price from $0.35 cents to $0.02 cents. All they needed to do was wait for him to do his next offering.

Doog, you say he took a $5 stock and reduced it to a Penny. How about use the the actual prices because of the Reverse split.

Its more dramatic to say he took a $50 dollar stock and dropped it to $0.15 cents and got it delisted.

Wim, ok, that made me laugh in an otherwise, non laughable event. LOL

So, now that we got booted to the OTC, I wonder if this board will go away? I can't say I know if IHUB follows unlisted stocks?

Fabius, I agree. its the same people who already had their hands in the pot and what does it say when its a warrant fund? they only short short short. Personally, I would rather see a 13D filing to pop the stock, that means someone actually wants to makes changes.

Cysonic, Interesting thought that IPCI would want Purdue Pharma tech added. I am not sure why. If Purdue themselves did not feel they had any claim over the original patents, why would IPCI ? If Purdue felt they had any claim over the patents they would have tried to add them in the first place. I will admit without having first hand knowledge I can't be sure one way or the other. So you could be right.

The reason I said this is bad is because the case was set for trial, until IPCI requested the stay. by adding another plaintiff this late it allows for numerous delays. because now the new Plaintiff would be afforded the same discovery and options to depose witnesses. In theory it could stall the case for another year.

well, The delay in game by IPCI is coming back to bite them. Now Purdue is adding additional defendants. Or at least wants too.

Full Contact, you got that right! a lot of bag holders. I'm not sure if you can actually say waiting for the reversal or is it more appropriate to say "hoping" for a reversal.

At this point, I am not sure what it will take to get it to reverse. Good news no longer brings any pops. Bad news and no news takes us down. Even if they refile the NDA, I bet we do not see any appreciation. My gut tells me the only thing that will reverse it is if he ever inks a deal for Rexista. Until then, good news, bad news, no news we will continue to drop and probably heading for another Reverse Split at the annual meeting so he can maintain compliance.

Freed, I wonder since we did not hear anything after that, if the human trials didn't produce the results they wanted? That could be why we never hear any more.

Lets face it,they didn't PR they were going to start the trials. this gives them the availability to keep the results quiet. Had the tests passed and proved PODRAS worked, all they would have needed to do was PR that and we would have never needed to Reverse Split in the first place in August! We would have easily went above $1 a share or $10 now Post split pricing.

So, I think the lack of news and the lack of those "quick deals" and his willingness to do a toxic offering, we have to look at as being negative and it probably didn't work.

I am actually starting to think the same about Rexista. The lack of release of the HAP studies makes me wonder if one didn't fail. Again, all he would need to do is release those top results and we would have popped from 50 cents to $1 and delisting would not be a problem. Here we are again. There has got to be a reason they did not refile the NDA in October as they felt they would.

Tilator, No, it was not empty talk. I am still here in this sinking ship. Being the bus driver does come with responsibility and I can not post a lot of what I would love too at times.

What I can say is the suit is filed and all briefs and counters were filed in time. At this point it is in the hands of the Judge. He has not indicated as of yet when he will make a determination to either throw the case out or allow it to proceed.

Shorts already covered! yet we are at all time low. not looking good as this is immediately after an FDA approval.

Too bad its a 13G and not a 13D. we need someone willing to take over this animal.

weezhul, I have to agree. big players are liquidating.

Fabious, I cant say I disagree with anything you wrote.

Impact, it doesn't matter. if you look at it daily or if you haven't looked at it in a year. I can tell you it goes down.
roughly last October we were trading at $11.00.

hmmm how many other stocks do you know get an FDA approval and go down in price? Then today we are down 10% on no news!

so let me get this right;
They PR what is good news and we go down.
They receive an FDA approval and we go down.
They PR bad news and we go way down.
They do not put out any news and we go down.

OK just checking making sure I got that right.

unfortunately no dead cat bounce, its just dead.

Doog, I think your post should be a sticky . heck, your chart doesn't even go down far enough to show $60.00 to $0.40 cents.

between bad management and the manipulation of this stock by larger share holders this should be a warning to anyone even thinking about it.

I for one have lost everything. believing the hype. We 1st round shareholders are dead. And the way it looks he is getting ready to kill round 2.

Doog, I'll second that. Not to mention Regabatin has been sitting since 2015 after having an IND meeting. Merely filing an IND with this company is meaningless.

eagle eyes. What should be and what is are two different things in this stock. Its heavily manipulated. we had 5 good news events and 1 negative which was not unexpected and instead of being up we are down to new lows. be warned. I felt the same thing and and have a $9.50 cost avg. I have lost around 300k in this stock. they have cash on hand just got an approval yet we sit at new lows. be forewarned. you will never be able to counter the manipulation.

Can everyone say MANIPULATION. lets see, we had 5 good PR's which included 3 deals inked, 1 new IND filed and 1 Generic approval. We had 1 bad PR, for a delisting notice, which was already a known event. Not to mention when we got the compliance notice we didn't see any price appreciation so when why the 39% drop? because the manipulators want to drag it down to a penny. Think about it. we do not go up on good news but go down on negative news and we constantly trade at lower highs and lower lows.

So we are now trading at all time lows. I am warning new comers now, this manipulation will kill you. I lost everything.

Lex, even if they do did we miss the boat seeing that 12 million shares were traded today? OR is this the effect of having the recent offering which effectively put 30 million more shares out on the float that they sold at 75 cents? maybe $1 isn't even achievable any longer and we all are screwed.

well thats a given as my cost just to break even needs to get back around $9.50 thats never going to happen.

INTL, the problem is the company hasn't released the PR. we have the volume, but no PR to follow it up with. As always they will screw up good news.

Lex, how sad the company doesn't put out the PR. we have volume but no real price appreciation.

Bernstein, This is why we have been trying to warn you about this stock. I for one have lost everything! This stock has ruined me. while you would expect it to run on news of submission of Rexista, DO NOT COUNT ON IT. the last time they originally submitted we saw no price appreciation. The reason given it was already price in as a known catalyst. Everyone knows they intend to refile, so why would it jump up?

As for being in 4 weeks, one could also argue it should be within the next week! They originally, stated that they wanted to refile in October or November. Then they changed that to "by year end" so does that mean still the end of fiscal year which would be the end of November or do they now push it back to December?

One has to ask, why can't they ever meet anything they say they are going to do? if one looks back at the January update they didn't meet one thing they said they were going to do.

Had they started the HAP studies when they said they wanted too, we would not still be waiting on the results by fiscal year end! Had they done the Podras trials and released those results we may have not needed to Reverse split. Had they Partnered Regabatin we would not needed to RS. had they refiled in September, as they stated in the update, they would not needed to RS or at least would not needed to complete a toxic dilution. Yet, they did succeed in spending 13 million dollars! on what? The October capital raise in 2017 was high and they said it was for raising monies to pay for the studies. so just what did they spend 13 million on this year and we have 0. absolutely 0 to show for it!

so please, do not be as foolish as I was. Look at these signs. Do not count on anything.

Doog, I agree. The PR's were terrible. It makes one wonder if they have any substantial value at all. They claim they have minimum purchase amounts. Why not at least say "with this we expect to bring in X amount of dollars per year just on minimum purchases"

They could have at least stated a timeline. That approval is hoped for within X amount time. They didn't even announce with whom they signed so the it could be verified.

It appears to reek of desperation, thinking it would pop the price up to $1 at least for a day, in order to stave off the delisting hearing notice that will be generated next week.

Wim, as of now he states he only wants IPCI for investment purposes. so, it makes sense with his initial investment at $11 and then again at $6. to cost average down. At the level and amount of shares he got, and then warrants at a penny, he has very little to lose even if Odidi does another Reverse split.

That's the beauty of buying this stuff as a fund. you can afford to tie up money for years and years. Unlike a little investor who needs the money out eventually.

Doog, Good luck to you. There is no hope for me. I have been trying to survive this for too long and now my wife is a year away from retirement. If that is what you can call it as she will probably need to take on a job somewhere. I wanted out much sooner and never thought I would be in this long. Now the longer I stayed the worse it made things. I wish I had a chance to invest in the MJ sector. But for me, I have to just take what I can get and invest in dividend producers for income.

Bernstein, The reason he did such a great job at Biovail is because he stayed in the LAB. Biovail was successful because they had team of people each good at their job.

That is what sucked me into this blackhole. Without a doubt, Odidi is a brilliant Scientist. But his management skills suck. This is where he was upset that the company was making money off his ideas and science and he thought screw that I'll work for myself.

Well he lacks the Business skills to make it work and his ego won't allow him to accept it. He has taken my investment from $40 a share to $0.53 a share. I now sit with a cost average of around $9.50 a share. Sinking more good money after bad knowing it would never get back up to $40. Thinking, The science is still good on these. all he needs to do is partner and I will be ok. And instead of partnering he turns them down and dilutes! Now look at the mess I am in! I am ruined financially. Yet, he claims he doing such a wonderful job.

The only thing I have left, is to warn people such a yourself what happened to me. You think it can't get worse, and it always does somehow.